Healthcare IT Today June 16, 2025
Combination Will Enable Faster, More Actionable Insights Across the Clinical and Commercial Lifecycle
Datavant, a leading health data platform company, today announced that it has signed an agreement to acquire Aetion, a leading real-world evidence (RWE) platform that powers critical decision-making in healthcare. With this acquisition, Aetion will join Datavant to deliver an end-to-end RWE platform, enabling healthcare and life sciences companies to more efficiently answer research questions about the clinical impact of therapies in development and in market.
This complementary combination unites two leaders to make RWE truly actionable, covering the full spectrum of services needed to deliver scientifically validated, transparent, and reproducible RWE accepted by global regulators, including the FDA and EMA. Aetion brings industry-leading technology, services, and...







